Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: July 2008
-
By Donald Zuhn — Last week, Senator Amy Klobuchar (D-MN) (at right) convened a hearing of the Joint Economic Committee (JEC), a bicameral Congressional Committee composed of ten members from both the Senate and the House of Representatives, to examine rising pharmaceutical prices and the impact of such price increases on the pharmaceutical…
-
By Donald Zuhn — In an article posted on the American.com website (the online version of The American magazine) on Tuesday, Dr. Aparna Mathur (at right), a Research Fellow at the American Enterprise Institute for Public Policy Research, argues that now is the time to begin lobbying against the patent reform bill that…
-
By Kevin E. Noonan — The Food and Drug Administration posted a notice on its website today that further restricts prescription of two erythropoietin drugs (Amgen’s Epogen®/Aransesp® and Johnson & Johnson’s Procrit®) to cancer patients. The notice is part of the FDA’s ongoing safety review of these drugs, and is a "follow-up" to…
-
By Christopher P. Singer — In a July 29, 2008 presentation at the Alzheimer’s Association International Conference on Alzheimer’s Disease (ICAD 2008) in Chicago, scientists involved in a collaboration between the University of Aberdeen and TauRx Therapeutics discussed data demonstrating that their candidate drug, rember, appears to slow the progress of the Alzheimer’s…
-
By Kevin E. Noonan — The U.S. Patent and Trademark Office announced today that Margaret Peterlin, Deputy Undersecretary of Commerce for Intellectual Property and Deputy Director of the USPTO will resign from her post some time in August. Deputy Director Peterlin (at left) has been a controversial figure in the Office, in part…
-
By Donald Zuhn — Managing Intellectual Property has released its sixth annual list of the most influential people in intellectual property (see "Politics, power and passion — this year’s MIP 50"). The MIP 50 appears in the magazine’s July/August issue, and can also be found on the magazine’s website (access to the online…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Shire LLC v. Actavis South Atlantic, LLC et al.2:08-cv-00287; filed July 24, 2008 in the Eastern District of Texas Infringement of U.S.…
-
August 11-12, 2008 – Advanced Patent Prosecution Workshop 2008: Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA August 10-15, 2008 – Advanced Courses (Patent Resources Group) – Washington, DC September 11, 2008 – Developments in Pharmaceutical and Biotech Patent Law (Practising Law Institute) – New York, NY September 11-12, 2008 –…
-
By Christopher P. Singer — EFS-Web Survey The U.S. Patent and Trademark Office is conducting a customer satisfaction survey relating to the experiences that registered users have had with EFS-Web. The deadline for filling out the survey is 11:30 p.m. (EDT) on Sunday, July 27, 2008. The USPTO estimates that the survey takes…
-
American Conference Institute (ACI) will be holding its Paragraph IV on Trial conference on November 19-20, 2008 in New York. At this conference, patent litigators experienced in representing both generic and brand name drug manufacturers will work through a mock trial based on a real world ANDA filing. The mock trial, Yankee Branded Pharmaceuticals v.…
Patent Docs 